Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by MrMugsyon Sep 11, 2022 11:55am
203 Views
Post# 34955128

RE:RE:AGM ...

RE:RE:AGM ...
Doccole wrote:

Hopefully Dano can keep the crew on schedule.  

we only go up from here? Right? 

say they release the biz study.....is that going to increase the need to purchase the stock? I can't imagine.  Insiders aren't buying now, can't imagine them buying anymore then....this is mostly held by retail, and I am betting it's going to need more to be pushed.  That's my thoughts, I hope I'm wrong.  



What I'm betting on has nothing to do with stock price movement- if/when the price moves, I'm ready.
Do I think there's more value than the price is indicating?  Sure do !
Do I think Q4 2022 is going to be super busy and potentially leading to good things?  Sure do !
Do I think there's room for some surprises in 2022?  Absolutely.
Will it happen and will the price jump?  I don't know !

---------------

Do I think the market for OTENA  is $13B+$12B = $25B ?  Not at all !
Am I right?  I don't know !

---------------

Do I think there are very cool opportunities for P2?  Sure do !
Is P2 a cakewalk ?  I hope so ... but ... I don't know !

---------------

Hope that helps    : )

It's never black and white - and - if it were easy, too many people that don't belong here would see themselves as stock heros.  We wouldn't want that either.

Hahaha !

<< Previous
Bullboard Posts
Next >>